Skip to main content

HTRF Anti-0-methyl K9 Histone H3 mAb Eu-Conjugate, 500 Assay Points

This Eu-cryptate conjugate allows specific detection of the K9Me0 motif on histone H3, as a result of demethylation or deacetylation enzymatic activity.

Feature Specification
Application Biochemical Enzymatic Assay

This Eu-cryptate conjugate allows specific detection of the K9Me0 motif on histone H3, as a result of demethylation or deacetylation enzymatic activity.

Product Variants
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).
Request More Information

Overview

Revvity offers a line of ready to use HTRF toolbox reagents for the construction of Histone H3 methyltransferase (HMT), demethylase (HDM) and deacetylase (HDAC) activity assays. This monoclonal antibody Eu-cryptate conjugate is specific for the histone H3K9Me0 methylation mark. It can be used for the development of biochemical assays with the highest levels of specificity and sensitivity, for the screening and study of both DMTs such as JMJD1A, and HDACs 1, 3-8, as well as SIRT1-3 and 6.

Specifications

Application
Biochemical Enzymatic Assay
Brand
HTRF
Detection Modality
HTRF
Molecular Modification
Methylation
Product Group
Fluorescent Reagent
Shipping Conditions
Shipped in Dry Ice
Target Class
Epigenetics
Technology
TR-FRET
Therapeutic Area
Metabolism/Diabetes
Neuroscience
Oncology & Inflammation
Unit Size
500 assay points

Video gallery

Resources

Are you looking for resources, click on the resource type to explore further.

1-2 of 2 Resources
Brochure Icon
Brochure
HTRF assays and reagents catalog

Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...

Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Scroll Icon